Deferred Income Tax Expense (Benefit) of CorMedix Inc. for 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
CorMedix Inc. quarterly Deferred Income Tax Expense (Benefit) in USD history and change rate for 30 Sep 2025.
  • CorMedix Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $59,700,000.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Quarterly (USD)

CorMedix Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $59,700,000 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.